Gene · 4882
Papers1,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell spatial analysis of tumor immune architecture in diffuse large B-cell lymphoma. | Blood Adv | 2022 | 35675517 | PubTator, text mining | PubMed |
| A genetic correlation scan identifies blood proteins associated with bone mineral density. | BMC Musculoskelet Disord | 2022 | 35659283 | PubTator, text mining | PubMed |
| Implicating effector genes at COVID-19 GWAS loci using promoter-focused Capture-C in disease-relevant immune cell types. | Genome Biol | 2022 | 35659055 | PubTator, text mining | PubMed |
| The Indirect Impact of COVID-19 on Major Clinical Outcomes of People With Parkinson's Disease or Parkinsonism: A Cohort Study. | Front Neurol | 2022 | 35651337 | PubTator, text mining | PubMed |
| Nitric oxide, salicylic acid and oxidative stress: Is it a perfect equilateral triangle? | Plant Physiol Biochem | 2022 | 35636332 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Oligo/Polysialylglycoconjugates in Cancer Cell Lines. | Int J Mol Sci | 2022 | 35628382 | PubTator, text mining | PubMed |
| Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma. | Cancer Med | 2022 | 35619325 | PubTator, text mining | PubMed |
| Emerging Concepts in Managing Malignancy in Kidney Transplant Patients. | Semin Nephrol | 2022 | 35618396 | PubTator, text mining | PubMed |
| Gene Expression Profiles of Treatment Response and Non-Response in Children With Juvenile Dermatomyositis. | ACR Open Rheumatol | 2022 | 35616642 | PubTator, text mining | PubMed |
| LCN2 is a new diagnostic biomarker and potential therapeutic target in idiopathic short stature. | J Cell Mol Med | 2022 | 35610759 | PubTator, text mining | PubMed |
| CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a/b to disinhibit PD-L1. | Cancer Sci | 2022 | 35579082 | PubTator, text mining | PubMed |
| Site-Specific Survival of Extra Nodal Diffuse Large B-Cell Lymphoma and Comparison With Gastrointestinal Diffuse Large B-Cell Lymphoma. | J Hematol | 2022 | 35573751 | PubTator, text mining | PubMed |
| Enrichment of TP53 alterations within GCB-like DNA subclassifications of diffuse large B-cell lymphoma after transition from de-novo to relapsed or refractory disease. | Blood Res | 2022 | 35551110 | PubTator, text mining | PubMed |
| The feasibility of injectable PRF (I-PRF) for bone tissue engineering and its application in oral and maxillofacial reconstruction: From bench to chairside. | Biomater Adv | 2022 | 35527147 | PubTator, text mining | PubMed |
| The pseudokinase domain in receptor guanylyl cyclases. | Methods Enzymol | 2022 | 35525553 | PubTator, text mining | PubMed |
| Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma. | Blood | 2022 | 35512184 | PubTator, text mining | PubMed |
| NT-proBNP as a predictor of death and cardiovascular events in patients with type 2 diabetes. | Diabetol Metab Syndr | 2022 | 35501909 | PubTator, text mining | PubMed |
| C-Type Natriuretic Peptide Regulates the Expression and Secretion of Antibacterial Peptide S100A7 in Goat Mammary Gland Through PKG/JNK/c-Jun Signaling Pathway. | Front Vet Sci | 2022 | 35498722 | PubTator, text mining | PubMed |
| Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma. | Front Endocrinol (Lausanne) | 2022 | 35498426 | PubTator, text mining | PubMed |
| DNA Repair-Related Gene Signature in Predicting Prognosis of Colorectal Cancer Patients. | Front Genet | 2022 | 35495147 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4882/papers?page=19